Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Infinity Pharmaceuticals Inc (NASDAQ:INFI)

3.06
Delayed Data
As of Mar 22
 -0.10 / -3.16%
Today’s Change
0.84
Today|||52-Week Range
6.63
+126.67%
Year-to-Date

Today’s Trading

Previous close3.16
Today’s open3.16
Day’s range3.01 - 3.21
Volume553,633
Average volume (3 months)1,048,434
Market cap$159.3M
Dividend yield--
Data as of 4:00pm ET, 03/22/2017

Growth & Valuation

Earnings growth (last year)+76.72%
Earnings growth (this year)--
Earnings growth (next 5 years)+101.00%
Revenue growth (last year)-82.83%
P/E ratioNM
Price/Sales3.58
Price/Book1.93

Competitors

 Today’s
change
Today’s
% change
COCPCocrystal Pharma Inc+0.01+6.82%
NYMXNymox Pharmaceutical...-0.01-0.31%
OCXOncoCyte Corp+0.08+1.49%
IMDZImmune Design Corp-0.05-0.76%
Data as of 4:00pm ET, 03/22/2017

Financials

Last reporting dateMarch 14, 2017
EPS forecast (this quarter)-$0.57
Annual revenue (last year)$18.7M
Annual profit (last year)-$30.1M
Net profit margin-160.77%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Adelene Q. Perkins
President, EVP, Chief Financial &
Business Officer
Lawrence E. Bloch
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs